Research Analysts’ Updated EPS Estimates for January 28th (ACRS, ASML, AUTO, BBVA, BLTE, BWB, CBLL, CCBG, CVLT, EBAY)

Research Analysts’ updated eps estimates for Wednesday, January 28th:

Aclaris Therapeutics (NASDAQ:ACRS) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $16.00 price target on the stock.

ASML (NASDAQ:ASML) had its buy rating reaffirmed by analysts at The Goldman Sachs Group, Inc..

ASML (NASDAQ:ASML) had its neutral rating reiterated by analysts at Jefferies Financial Group Inc..

Auto Trader Group (LON:AUTO) had its underweight rating reaffirmed by analysts at JPMorgan Chase & Co..

Banco Bilbao Viscaya Argentaria (NYSE:BBVA) was downgraded by analysts at Royal Bank Of Canada from an outperform rating to a sector perform rating.

Belite Bio (NASDAQ:BLTE) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $185.00 price target on the stock.

Bridgewater Bancshares (NASDAQ:BWB) had its buy rating reaffirmed by analysts at DA Davidson. The firm currently has a $23.00 price target on the stock.

CeriBell (NASDAQ:CBLL) had its buy rating reissued by analysts at BTIG Research. BTIG Research currently has a $30.00 target price on the stock.

Capital City Bank Group (NASDAQ:CCBG) was downgraded by analysts at Keefe, Bruyette & Woods from an outperform rating to a market perform rating. They currently have $45.00 price target on the stock, down from their previous price target of $47.00.

CommVault Systems (NASDAQ:CVLT) had its buy rating reissued by analysts at Truist Financial Corporation. Truist Financial Corporation currently has a $155.00 price target on the stock, down from their previous price target of $175.00.

eBay (NASDAQ:EBAY) had its market outperform rating reiterated by analysts at Citizens Jmp. Citizens Jmp currently has a $115.00 price target on the stock.

Enova International (NYSE:ENVA) had its buy rating reiterated by analysts at BTIG Research. They currently have a $199.00 price target on the stock.

FDM Group (LON:FDM) had its house stock rating reaffirmed by analysts at Shore Capital.

F5 (NASDAQ:FFIV) had its hold rating reaffirmed by analysts at Needham & Company LLC.

Genmab A/S (NASDAQ:GMAB) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $39.00 target price on the stock.

Robinhood Markets (NASDAQ:HOOD) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $135.00 price target on the stock.

Hope Bancorp (NASDAQ:HOPE) had its buy rating reaffirmed by analysts at DA Davidson. They currently have a $14.50 target price on the stock.

Intel (NASDAQ:INTC) had its neutral rating reaffirmed by analysts at Sanford C. Bernstein.

Opus Genetics (NASDAQ:IRD) had its buy rating reaffirmed by analysts at BTIG Research. The firm currently has a $7.00 price target on the stock.

KKR & Co. Inc. (NYSE:KKR) was upgraded by analysts at HSBC Holdings plc from a hold rating to a buy rating. They currently have $144.00 target price on the stock.

Coca Cola Femsa (NYSE:KOF) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. The firm currently has $100.00 target price on the stock.

Novogen (NASDAQ:KZIA) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $18.00 price target on the stock.

Louisiana-Pacific (NYSE:LPX) had its buy rating reaffirmed by analysts at DA Davidson. The firm currently has a $117.00 price target on the stock.

Stride (NYSE:LRN) had its outperform rating reaffirmed by analysts at Barrington Research. Barrington Research currently has a $125.00 price target on the stock.

Marston’s (LON:MARS) had its buy rating reaffirmed by analysts at Shore Capital.

Microchip Technology (NASDAQ:MCHP) was upgraded by analysts at Bank of America Corporation from a neutral rating to a buy rating. They currently have $95.00 price target on the stock.

NewRiver REIT (LON:NRR) had its house stock rating reiterated by analysts at Shore Capital.

NVIDIA (NASDAQ:NVDA) had its buy rating reissued by analysts at Sanford C. Bernstein.

OceanFirst Financial (NASDAQ:OCFC) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

ON (NYSE:ONON) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $52.00 price target on the stock.

ON (NYSE:ONON) had its outperform rating reissued by analysts at Telsey Advisory Group. The firm currently has a $65.00 target price on the stock.

Plains All American Pipeline (NYSE:PAA) was downgraded by analysts at Bank of America Corporation from a neutral rating to an underperform rating. The firm currently has $19.00 target price on the stock.

Paragon Banking Group (LON:PAG) had its outperform rating reiterated by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a GBX 1,050 price target on the stock.

Plains GP (NYSE:PAGP) was downgraded by analysts at Bank of America Corporation from a neutral rating to an underperform rating. Bank of America Corporation currently has $19.00 target price on the stock.

Palo Alto Networks (NASDAQ:PANW) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $230.00 price target on the stock.

Personal Group (LON:PGH) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 416 price target on the stock.

Poolbeg Pharma (LON:POLB) had its house stock rating reissued by analysts at Shore Capital.

PRA Group (NASDAQ:PRAA) had its market perform rating reissued by analysts at Citizens Jmp.

PayPal (NASDAQ:PYPL) was downgraded by analysts at Rothschild & Co Redburn from a neutral rating to a sell rating. The firm currently has $50.00 price target on the stock.

D-Wave Quantum (NYSE:QBTS) had its buy rating reissued by analysts at Rosenblatt Securities. The firm currently has a $43.00 price target on the stock.

Qorvo (NASDAQ:QRVO) had its hold rating reaffirmed by analysts at Benchmark Co..

Rio Tinto (NYSE:RIO) was downgraded by analysts at Morgan Stanley from an overweight rating to an equal weight rating.

Roper Technologies (NASDAQ:ROP) had its market perform rating reiterated by analysts at Oppenheimer Holdings, Inc..

Roper Technologies (NASDAQ:ROP) had its hold rating reaffirmed by analysts at Argus.

Synchrony Financial (NYSE:SYF) was upgraded by analysts at Compass Point from a neutral rating to a buy rating. The firm currently has $96.00 target price on the stock.

Texas Instruments (NASDAQ:TXN) was upgraded by analysts at Bank of America Corporation from an underperform rating to a neutral rating. They currently have $235.00 price target on the stock, up from their previous price target of $185.00.

United Parcel Service (NYSE:UPS) was upgraded by analysts at HSBC Holdings plc from a hold rating to a buy rating.

Visa (NYSE:V) was upgraded by analysts at Rothschild & Co Redburn from a neutral rating to a buy rating. Rothschild & Co Redburn currently has $385.00 target price on the stock.

V.F. (NYSE:VFC) had its market perform rating reissued by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $16.00 target price on the stock.

Western Alliance Bancorporation (NYSE:WAL) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. JPMorgan Chase & Co. currently has $105.00 target price on the stock.

Receive News & Ratings for Aclaris Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclaris Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.